Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Syndromes, Hereditary

Explore clinical trials studying Neoplastic Syndromes, Hereditary. Study availability and eligibility vary by location and protocol.

869 public trials 154 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Syndromes, Hereditary trial results

Active, Not Recruiting

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

NCT02978625

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Anaplastic Large Cell Lymphoma, ALK-Positive, +86 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.

NCT03363217

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +29 more
Locations
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Children and Women's Health Centre of British Colombia Vancouver, British Columbia, Canada
  • IWK Health Centre Halifax, Nova Scotia, Canada
  • The Hospital for Sick Children Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

MElanoma Research Lymph Node Prediction Implementation National_001

NCT04759781

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +30 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • University of Kentucky Lexington, Kentucky, United States
  • University of Louisville Louisville, Kentucky, United States
View Trial Details
Active, Not Recruiting

Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

NCT02962414

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +17 more
Locations
  • TGen APNNA Phoenix, Arizona, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • UCSF Benioff Children s Hospital Oakland, California, United States
  • Rady Children s Hospital San Diego, California, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

NCT06392009

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Focal Cortical Dysplasia, +14 more
Locations
  • Queensland Children Hospital South Brisbane, Australia
  • University Hospitals Leuven, Pediatric Neurology Leuven, Belgium
  • Alberta Children's Hospital Calgary, Canada
  • The Hospital for Sick Children (Sick Kids) Toronto, Canada
View all 18 locations
View Trial Details

Related conditions